Tamiflu data show very low resistance: Roche
Swiss pharmaceutical group Roche Holding AG said on Wednesday new data showed patients using its anti-flu drug Tamiflu rarely developed resistance to it.
The data, published by the United Nations’ World Health Organisation, showed resistance of around 0.3 percent to Tamiflu, also called oseltamivir, during the influenza seasons in which there had been substantial Tamiflu use in Japan.
Duloxetine improves generalized anxiety disorder
The results of a study published in the April issue of the Journal of Clinical Psychiatry indicate that treatment with duloxetine, sold under the trade name Cymbalta, improves functioning and enhances the quality of life in patients with generalized anxiety disorder.
Dr. Jean Endicott, of Columbia School of Medicine, New York, and colleagues examined the effectiveness of duloxetine in patients with generalized anxiety disorder who participated in three studies.
Store ads spur teens to smoke, U.S. study finds
The more cigarette marketing teens are exposed to in retail stores, the more likely they are to smoke, researchers reported on Monday in a U.S. study they said supports even tighter restrictions on tobacco ads.
Point-of-sale advertising can encourage teens to try smoking, the team reported in the Archives of Pediatrics and Adolescent Medicine.
